Retrieved October 19, 2019
Regaining ones energy should make it easier for people to stay motivated and active
Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context
10.1016/j.brs.2021.08.001 Brain Stimul
Tirzepatide is a first-in-class dual incretin receptor agonist a single molecule that activates both the GIP (glucose-dependent insulinotropic polypeptide) and the GLP-1 (glucagon-like peptide-1) receptors, which is why it is often nicknamed a twincretin. [7] By engaging two incretin pathways it enhances glucose-dependent insulin secretion, promotes satiety, and delays gastric emptying, producing large effects on both glycemic control and bodyweight
Some experience mild side effects, such as slight redness at the injection site, but these typically fade quickly